Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Cancer | journal | 16.955 Q1 | 505 | 105 | 337 | 9854 | 9592 | 186 | 27.84 | 93.85 | 35.96 |  |
| 2 | Molecular Cancer | journal | 6.896 Q1 | 196 | 162 | 477 | 12537 | 15669 | 446 | 35.77 | 77.39 | 41.54 | |
| 3 | Signal Transduction and Targeted Therapy | journal | 5.157 Q1 | 117 | 425 | 384 | 31800 | 7038 | 249 | 17.80 | 74.82 | 41.75 | |
| 4 | Journal of the National Cancer Institute | journal | 4.760 Q1 | 387 | 280 | 585 | 9765 | 5011 | 416 | 7.62 | 34.88 | 47.62 | |
| 5 | Journal of Hematology and Oncology | journal | 4.241 Q1 | 144 | 199 | 433 | 15362 | 8406 | 425 | 19.97 | 77.20 | 41.33 | |
| 6 | Leukemia | journal | 4.030 Q1 | 219 | 400 | 1024 | 14193 | 9996 | 822 | 9.60 | 35.48 | 41.86 | |
| 7 | Journal for ImmunoTherapy of Cancer | journal | 3.450 Q1 | 117 | 551 | 994 | 23687 | 12239 | 988 | 10.91 | 42.99 | 42.42 | |
| 8 | Neuro-Oncology | journal | 3.097 Q1 | 163 | 275 | 634 | 7778 | 4956 | 430 | 7.38 | 28.28 | 42.10 | |
| 9 | European Journal of Cancer | journal | 2.865 Q1 | 245 | 589 | 1117 | 17344 | 8917 | 896 | 8.03 | 29.45 | 43.46 | |
| 10 | Oncogene | journal | 2.360 Q1 | 370 | 517 | 1451 | 26916 | 12964 | 1441 | 8.00 | 52.06 | 40.98 | |
| 11 | Cancer Communications | journal | 2.357 Q1 | 79 | 105 | 229 | 6574 | 2159 | 180 | 9.45 | 62.61 | 39.61 | |
| 12 | Journal of Experimental and Clinical Cancer Research | journal | 2.350 Q1 | 120 | 361 | 978 | 23361 | 11402 | 977 | 11.40 | 64.71 | 42.77 | |
| 13 | British Journal of Cancer | journal | 2.272 Q1 | 272 | 461 | 1166 | 22279 | 8883 | 1031 | 7.66 | 48.33 | 44.14 | |
| 14 | Breast Cancer Research | journal | 2.225 Q1 | 175 | 111 | 434 | 5041 | 3312 | 428 | 7.90 | 45.41 | 51.12 | |
| 15 | Cell Death and Disease | journal | 2.099 Q1 | 164 | 1101 | 3054 | 54830 | 28044 | 2993 | 8.83 | 49.80 | 42.63 | |
| 16 | Advances in Biological Regulation | journal | 1.534 Q1 | 69 | 36 | 141 | 3689 | 808 | 134 | 5.95 | 102.47 | 48.94 | |
| 17 | Molecular Therapy - Oncolytics | journal | 1.530 Q1 | 42 | 181 | 268 | 10874 | 1713 | 268 | 6.14 | 60.08 | 40.29 | |
| 18 | ESMO Open | journal | 1.524 Q1 | 60 | 265 | 431 | 10001 | 2104 | 351 | 5.10 | 37.74 | 43.26 | |
| 19 | Prostate Cancer and Prostatic Diseases | journal | 1.519 Q1 | 78 | 144 | 240 | 5117 | 1372 | 223 | 5.64 | 35.53 | 28.97 | |
| 20 | Oral Oncology | journal | 1.421 Q1 | 137 | 432 | 1064 | 11788 | 4706 | 753 | 4.12 | 27.29 | 34.97 | |
| 21 | Endocrine-Related Cancer | journal | 1.416 Q2 | 146 | 106 | 361 | 6383 | 2149 | 345 | 6.05 | 60.22 | 48.13 | |
| 22 | Cell Death Discovery | journal | 1.399 Q2 | 58 | 368 | 350 | 17084 | 2117 | 333 | 6.67 | 46.42 | 41.47 | |
| 23 | Experimental Hematology and Oncology | journal | 1.301 Q2 | 42 | 58 | 101 | 3483 | 670 | 100 | 7.16 | 60.05 | 39.63 | |
| 24 | Cancer Gene Therapy | journal | 1.207 Q2 | 99 | 98 | 163 | 5506 | 852 | 155 | 5.37 | 56.18 | 45.13 | |
| 25 | Carcinogenesis | journal | 1.178 Q2 | 223 | 156 | 490 | 7432 | 2375 | 471 | 4.25 | 47.64 | 38.61 | |
| 26 | Cancer Medicine | journal | 1.144 Q2 | 84 | 802 | 2176 | 30919 | 10517 | 2171 | 4.64 | 38.55 | 39.82 | |
| 27 | BMC Cancer | journal | 1.134 Q2 | 160 | 1320 | 3727 | 51492 | 18083 | 3726 | 4.52 | 39.01 | 39.02 | |
| 28 | Cancer Cell International | journal | 1.099 Q2 | 80 | 668 | 1113 | 36277 | 6711 | 1113 | 6.11 | 54.31 | 41.46 | |
| 29 | Hematological Oncology | journal | 0.971 Q2 | 54 | 113 | 350 | 3239 | 1029 | 277 | 3.08 | 28.66 | 47.90 | |
| 30 | Epigenomics | journal | 0.894 Q2 | 77 | 141 | 403 | 7994 | 1725 | 380 | 3.95 | 56.70 | 49.89 | |
| 31 | Leukemia Research | journal | 0.865 Q2 | 96 | 167 | 468 | 4864 | 1211 | 339 | 2.47 | 29.13 | 46.36 | |
| 32 | Infectious Agents and Cancer | journal | 0.837 Q3 | 47 | 69 | 160 | 3477 | 544 | 159 | 3.22 | 50.39 | 46.92 | |
| 33 | Future Oncology | journal | 0.836 Q3 | 90 | 441 | 1030 | 19469 | 3421 | 960 | 3.34 | 44.15 | 38.20 | |
| 34 | Journal of Oral Pathology and Medicine | journal | 0.774 Q3 | 95 | 127 | 411 | 3812 | 1803 | 388 | 4.38 | 30.02 | 46.58 | |
| 35 | Leukemia and Lymphoma | journal | 0.741 Q3 | 102 | 491 | 1496 | 14227 | 2814 | 884 | 1.76 | 28.98 | 44.57 | |
| 36 | FASEB BioAdvances | journal | 0.713 Q3 | 18 | 91 | 118 | 4595 | 335 | 113 | 2.84 | 50.49 | 40.71 | |
| 37 | International Journal of Hyperthermia | journal | 0.709 Q3 | 98 | 197 | 601 | 7870 | 2231 | 574 | 3.58 | 39.95 | 36.22 | |
| 38 | Japanese Journal of Clinical Oncology | journal | 0.679 Q3 | 95 | 298 | 552 | 7186 | 1562 | 505 | 2.73 | 24.11 | 19.69 | |
| 39 | ecancermedicalscience | journal | 0.665 Q3 | 47 | 183 | 392 | 6364 | 1182 | 389 | 3.12 | 34.78 | 45.14 | |
| 40 | Cancer Treatment and Research Communications | journal | 0.520 Q3 | 23 | 227 | 161 | 9840 | 314 | 151 | 2.07 | 43.35 | 41.91 | |
| 41 | Molecular and Cellular Oncology | journal | 0.501 Q4 | 37 | 104 | 334 | 1056 | 477 | 267 | 1.36 | 10.15 | 40.00 | |
| 42 | Molecular and Clinical Oncology | journal | 0.393 Q4 | 19 | 262 | 345 | 7685 | 633 | 344 | 1.85 | 29.33 | 28.56 | |
| 43 | Cancer Reports | journal | 0.320 Q4 | 18 | 117 | 148 | 4337 | 225 | 142 | 1.59 | 37.07 | 36.02 | |
| 44 | European Journal of Cancer, Supplement | journal | 0.248 Q4 | 29 | 3 | 11 | 75 | 16 | 11 | 1.45 | 25.00 | 40.00 | |
| 45 | Function | journal | 16 | 79 | 23 | 2834 | 102 | 19 | 4.43 | 35.87 | 36.27 | | |
| 46 | NAR Cancer | journal | 17 | 53 | 37 | 4464 | 180 | 36 | 4.86 | 84.23 | 44.76 | | |
| 47 | npj Precision Oncology | journal | 36 | 100 | 93 | 5004 | 1011 | 92 | 9.82 | 50.04 | 39.16 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data